Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients

Transplant Proc. 2013 Jan-Feb;45(1):369-75. doi: 10.1016/j.transproceed.2012.09.116.

Abstract

Introduction: Arrhythmias occur frequently after heart transplantation (HT), but knowledge of their impact on long-term outcomes is limited. This study sought to investigate the characteristics of the arrhythmias among biatrial orthotopic HT patients during long-term follow-up.

Methods: This study included 217 patients who received biatrial orthotopic HT. Patients were classified into 5 groups according to the arrhythmia episodes that occurred >1 month after HT: no arrhythmias (group 1; n = 149); atrial tachyarrhythmias only (group 2; n = 34); ventricular tachyarrhythmias only (group 3; n = 9); bradyarrhythmias only (group 4; n = 7); or double/triple arrhythmias (group 5; n = 18). We analyzed their long-term outcomes respectively.

Results: During 83 ± 51 months of follow-up, all-cause mortality rates were higher in groups 3 (88.9%) and 5 (72.2%) compared with the other groups (groups 1, 2, and 4: 21.5%, 41.2%, and 57.1%, respectively; P < .001). Cardiovascular mortality rates were higher in groups 4 (42.9%) and 5 (61.1%) compared with the other groups (groups 1, 2, and 3: 8.1%, 20.6%, and 0% respectively; P < .001). Noncardiovascular mortality rate was greater in group 3 (88.9%) compared with the other groups (groups 1, 2, 4, and 5: 13.4%, 20.6%, 14.3%, and 11.1%, respectively; P < .001). Sudden death rates were higher in groups 4 (42.9%) and 5 (44.4%) compared with the other groups (groups 1, 2, and 3: 7.4%, 8.8%, and 0%, respectively; P < .001).

Conclusion: Patients with posttransplantation arrhythmias experienced significantly worse clinical outcomes.

MeSH terms

  • Adult
  • Aged
  • Arrhythmias, Cardiac / classification
  • Arrhythmias, Cardiac / mortality
  • Arrhythmias, Cardiac / therapy*
  • Biopsy
  • Coronary Angiography
  • Cyclosporine / therapeutic use
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Heart Transplantation / methods*
  • Humans
  • Male
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Myocardium / pathology
  • Prednisolone / therapeutic use
  • Retrospective Studies
  • Tacrolimus / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Cyclosporine
  • Prednisolone
  • Mycophenolic Acid
  • Tacrolimus